Source:http://linkedlifedata.com/resource/pubmed/id/18722784
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-11-10
|
pubmed:abstractText |
Irinotecan is an active drug in the first and subsequent lines of chemotherapy for patients with advanced colorectal cancer. Frequently, the elderly patients are excluded from receiving irinotecan alone or in combination, and on many occasions these patients receive an initial reduced dose of this drug. This revision has been focused in the role of irinotecan in elderly patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1040-8428
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
250-5
|
pubmed:meshHeading |
pubmed-meshheading:18722784-Aged,
pubmed-meshheading:18722784-Aged, 80 and over,
pubmed-meshheading:18722784-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:18722784-Camptothecin,
pubmed-meshheading:18722784-Clinical Trials as Topic,
pubmed-meshheading:18722784-Colorectal Neoplasms,
pubmed-meshheading:18722784-Female,
pubmed-meshheading:18722784-Health Services for the Aged,
pubmed-meshheading:18722784-Humans,
pubmed-meshheading:18722784-Male
|
pubmed:year |
2008
|
pubmed:articleTitle |
Irinotecan in the treatment of elderly patients with advanced colorectal cancer.
|
pubmed:affiliation |
Medical Oncology Department, San Carlos Hospital, c/Martin Lagos s/n, 28040 Madrid, Spain. giuseppedilorenzoncol@hotmail.com <giuseppedilorenzoncol@hotmail.com>
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Review
|